Neurofeedback
- Therapy · Cognitive-behavioral
- Mixed or contested
- Published October 19, 2026
- 11 sources
- 4 min read
In short
Related in this topic
On this page
Key facts
- Tradition
- Cognitive-behavioral
- Developed by
- No single developer; EEG operant-conditioning studies from the 1970s, including training of the sensorimotor rhythm for epilepsy, and the first reports in ADHD in 1976
- Origin
- 1970s onward
- Typical format
- Repeated training sessions (30 over 15 weeks in one adult trial) in which EEG or fMRI activity is displayed in real time and reinforced when it changes in the trained direction
- Most researched for
- ADHD in children and adults; Drug-resistant epilepsy; Psychiatric disorders (fMRI neurofeedback)
- Also known as
- EEG biofeedback; EEG neurofeedback; Real-time fMRI neurofeedback
- Topics
- Behaviorism
State of the evidence
Mixed or contestedMeta-analyses of ADHD trials find benefits when symptoms are rated by people close to the treatment, such as parents, but not when raters are probably blinded or the comparison is a sham or active control[1][2]. A double-blind trial in 142 children and a triple-blind trial in 118 adults found neurofeedback no better than sham neurofeedback, with large improvement in both arms[3][4]. Some meta-analyses report positive effects, including on inattention rated by possibly blinded evaluators[5], and real-time fMRI neurofeedback shows a small effect on psychiatric symptoms across 17 studies[6]. Whether the specific brain signal matters remains unresolved[7].
Evidence labels summarise the research literature; they are not recommendations. How labels are assigned
Neurofeedback is a psychophysiological procedure in which a person receives online feedback of their own neural activity for the purpose of learning to regulate it[8]. It is a form of biofeedback in which the signal comes from the brain, and its practitioners describe it as changing EEG activity by means of operant conditioning, with activity in the trained direction reinforced[9]. Sitaram and colleagues describe it as a progenitor of brain–machine interfaces, and note that in experimental work, learning to control specific neural activity has been shown to change specific behaviors[8].
The central claim of neurofeedback is specific: that learning to change a particular brain signal is what produces clinical benefit. That claim is separate from the observation that people improve during a course of neurofeedback, and the research on ADHD has been designed largely to tell the two apart[1][7].
EEG and fMRI neurofeedback
EEG neurofeedback, the older form, records electrical activity from the scalp. The most common approach trains activity in particular frequency bands[1]. Protocols for ADHD have trained a reduction in the ratio of theta to beta activity[3][4]. Early epilepsy studies mostly reinforced the sensorimotor rhythm, and one trained slow cortical potentials[9].
Real-time functional magnetic resonance imaging (fMRI) neurofeedback displays the activity of a targeted brain region measured in the scanner[8]. It remains an experimental treatment for psychiatric disorders[6].
Early use in epilepsy
Neurofeedback was applied to seizure disorders from the 1970s. A meta-analysis of studies published between 1970 and 2005 found 63 reports but only 10 with enough outcome information to analyze; most of the literature consisted of case series too small to establish efficacy[9]. All patients had seizures that medical treatment had not controlled, and 64 of 87 reported fewer weekly seizures after training, a significant reduction overall[9]. The analysis compared seizure frequency before and after training without a control condition, so it shows change after training rather than an effect of the training itself[9].
ADHD trials: open and blinded ratings
ADHD has the largest neurofeedback literature, and its results depend on who rates the outcome. A 2009 meta-analysis that applied the efficacy guidelines of two biofeedback and neurofeedback societies found large effects on inattention and impulsivity and a medium effect on hyperactivity, and concluded that neurofeedback for ADHD could be considered efficacious and specific; it counted three randomized studies with semi-active control groups as credible sham controls, and noted that hyperactivity was probably most sensitive to nonspecific treatment factors[10].
Analyses by the European ADHD Guidelines Group distinguished ratings by people closest to the therapeutic setting from ratings by assessors probably blind to the treatment. In a 2013 meta-analysis of nonpharmacological treatments, neurofeedback was effective by the first kind of rating but not significantly so by the second, and the authors concluded that better evidence from blinded assessments was needed[11]. A 2016 meta-analysis of 13 trials with 520 participants found the same pattern: a significant effect on symptoms rated by the least blinded assessors (standardized mean difference 0.35), and no significant effect with probably blinded ratings or in trials with active or sham controls. Effects on laboratory measures of inhibition and attention were not significant, and only four studies checked whether participants had actually learned to change their brain activity[1].
A 2025 update with 38 randomized trials and 2,472 participants found no improvement in probably blinded ratings of total ADHD symptoms (0.04). A small improvement appeared when the analysis was restricted to trials using established standard protocols (0.21), and among neuropsychological outcomes only processing speed improved. The authors concluded that neurofeedback did not appear to benefit people with ADHD meaningfully at the group level[2]. Not every synthesis agrees: a 2021 meta-analysis of 17 trials found that neurofeedback improved inattention even when symptoms were rated by possibly blinded evaluators[5].
Sham-controlled trials
Two trials compared neurofeedback with a convincing sham. In adults with ADHD, 118 participants were randomized to 30 sessions of theta-to-beta neurofeedback, sham neurofeedback, or group meta-cognitive therapy in a triple-blind design. Self-reported symptoms fell substantially in all three groups, with no difference between real and sham neurofeedback or between neurofeedback and group therapy[4] .
In children, a two-site double-blind trial randomized 144 children aged 7 to 10 with moderate or severe ADHD and a high theta/beta ratio to theta/beta downtraining or a control that replayed prerecorded EEG with the child’s own artifacts. Blinding was excellent. Both groups improved greatly on parent- and teacher-rated inattention (d = 1.5), but neurofeedback was not superior at the end of treatment or at 13 months, and responders were 61% with neurofeedback and 54% with the control[3]. In the adult trial no treatment-related serious adverse events were reported, and in the child trial adverse events were distributed proportionally between the two arms[4][3].
Real-time fMRI neurofeedback
The first meta-analysis of fMRI neurofeedback for psychiatric disorders identified 17 studies. It found a medium effect on the targeted neural activity during training, a large effect after training without feedback, a small effect on symptoms (g = 0.37) and no significant effect on cognition, and concluded that more research is needed on how the method works and for whom[6].
The unresolved question of specificity
Thibault and Raz argue that few experiments isolate receiving feedback from a specific brain signal as necessary for the benefits claimed, and that psychosocial factors such as motivation and expectation, rather than the neurobiological target, seem to drive clinical improvement across disorders[7]. The ADHD trials fit that reading: improvement was large in sham arms[3][4], and effects disappeared under blinded rating[1][2]. The guideline group’s reviews propose that future trials use standard protocols and verify that learning occurred, and the 2025 review suggests looking for the individuals who may benefit[1][2]. Until such trials succeed, the specific contribution of the brain signal remains unproven.
Sources11
Numbered in order of first citation.
- 1.Cortese, S., Ferrin, M., Brandeis, D., Holtmann, M., Aggensteiner, P., Daley, D., Santosh, P., Simonoff, E., Stevenson, J., Stringaris, A., Sonuga-Barke, E. J., Asherson, P., Banaschewski, T., Brandeis, D., Buitelaar, J., Coghill, D., Cortese, S., Daley, D., Danckaerts, M., … Zuddas, A. (2016). Neurofeedback for attention-deficit/hyperactivity disorder: Meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials. Journal of the American Academy of Child & Adolescent Psychiatry, 55(6), 444–455. https://doi.org/10.1016/j.jaac.2016.03.007
- 2.Westwood, S. J., Aggensteiner, P.-M., Kaiser, A., Nagy, P., Donno, F., Merkl, D., Balia, C., Goujon, A., Bousquet, E., Capodiferro, A. M., Derks, L., Purper-Ouakil, D., Carucci, S., Holtmann, M., Brandeis, D., Cortese, S., Sonuga-Barke, E. J. S., European ADHD Guidelines Group (EAGG), Baeyens, D., … Wong, I. C. (2025). Neurofeedback for attention-deficit/hyperactivity disorder: A systematic review and meta-analysis. JAMA Psychiatry, 82(2), 118–129. https://doi.org/10.1001/jamapsychiatry.2024.3702
- 3.Neurofeedback Collaborative Group (2021). Double-blind placebo-controlled randomized clinical trial of neurofeedback for attention-deficit/hyperactivity disorder with 13-month follow-up. Journal of the American Academy of Child & Adolescent Psychiatry, 60(7), 841–855. https://doi.org/10.1016/j.jaac.2020.07.906
- 4.Schönenberg, M., Wiedemann, E., Schneidt, A., Scheeff, J., Logemann, A., Keune, P. M., & Hautzinger, M. (2017). Neurofeedback, sham neurofeedback, and cognitive-behavioural group therapy in adults with attention-deficit hyperactivity disorder: a triple-blind, randomised, controlled trial. The Lancet Psychiatry, 4(9), 673–684. https://doi.org/10.1016/S2215-0366(17)30291-2
- 5.Riesco-Matías, P., Yela-Bernabé, J. R., Crego, A., & Sánchez-Zaballos, E. (2021). What do meta-analyses have to say about the efficacy of neurofeedback applied to children with ADHD? Review of previous meta-analyses and a new meta-analysis. Journal of Attention Disorders, 25(4), 473–485. https://doi.org/10.1177/1087054718821731
- 6.Dudek, E., & Dodell-Feder, D. (2021). The efficacy of real-time functional magnetic resonance imaging neurofeedback for psychiatric illness: A meta-analysis of brain and behavioral outcomes. Neuroscience & Biobehavioral Reviews, 121, 291–306. https://doi.org/10.1016/j.neubiorev.2020.12.020
- 7.Thibault, R. T., & Raz, A. (2017). The psychology of neurofeedback: Clinical intervention even if applied placebo. American Psychologist, 72(7), 679–688. https://doi.org/10.1037/amp0000118
- 8.Sitaram, R., Ros, T., Stoeckel, L., Haller, S., Scharnowski, F., Lewis-Peacock, J., Weiskopf, N., Blefari, M. L., Rana, M., Oblak, E., Birbaumer, N., & Sulzer, J. (2017). Closed-loop brain training: the science of neurofeedback. Nature Reviews Neuroscience, 18(2), 86–100. https://doi.org/10.1038/nrn.2016.164
- 9.Tan, G., Thornby, J., Hammond, D. C., Strehl, U., Canady, B., Arnemann, K., & Kaiser, D. A. (2009). Meta-analysis of EEG biofeedback in treating epilepsy. Clinical EEG and Neuroscience, 40(3), 173–179. https://doi.org/10.1177/155005940904000310
- 10.Arns, M., de Ridder, S., Strehl, U., Breteler, M., & Coenen, A. (2009). Efficacy of neurofeedback treatment in ADHD: The effects on inattention, impulsivity and hyperactivity: A meta-analysis. Clinical EEG and Neuroscience, 40(3), 180–189. https://doi.org/10.1177/155005940904000311
- 11.Sonuga-Barke, E. J., Brandeis, D., Cortese, S., Daley, D., Ferrin, M., Holtmann, M., Stevenson, J., Danckaerts, M., van der Oord, S., Döpfner, M., Dittmann, R. W., Simonoff, E., Zuddas, A., Banaschewski, T., Buitelaar, J., Coghill, D., Hollis, C., Konofal, E., Lecendreux, M., … European ADHD Guidelines Group (2013). Nonpharmacological interventions for ADHD: Systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. American Journal of Psychiatry, 170(3), 275–289. https://doi.org/10.1176/appi.ajp.2012.12070991
Further reading
- Sitaram, R., Ros, T., Stoeckel, L., Haller, S., Scharnowski, F., Lewis-Peacock, J., Weiskopf, N., Blefari, M. L., Rana, M., Oblak, E., Birbaumer, N., & Sulzer, J. (2017). Closed-loop brain training: the science of neurofeedback. Nature Reviews Neuroscience, 18(2), 86–100. https://doi.org/10.1038/nrn.2016.164
- Thibault, R. T., & Raz, A. (2017). The psychology of neurofeedback: Clinical intervention even if applied placebo. American Psychologist, 72(7), 679–688. https://doi.org/10.1037/amp0000118
Related entries 5
- BiofeedbackTherapy
- Operant conditioningConcept
- Cognitive behavioral therapy(CBT)Therapy
- BehaviorismTopic
- Bessel van der KolkFigure
Cite this entry
APA 7
Psych Dictionary. (2026, October 19). Neurofeedback. In Psych Dictionary. https://www.psychdictionary.com/therapies/neurofeedback
MLA 9
“Neurofeedback.” Psych Dictionary, 19 Oct. 2026, www.psychdictionary.com/therapies/neurofeedback.